Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Visualizing enveloping layer glycans during zebrafish early embryogenesis
2010 StandoutNobel
Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barre syndrome
2005
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
The repertoire of glycan determinants in the human glycome
2009
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures
2000
Anti-GT1a IgG in Guillain-Barre syndrome
2002
Human Leukocyte Antigen (HLA) Class I Defects in Head and Neck Cancer: Molecular Mechanisms and Clinical Significance
2005
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
1996
Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases
2010
Developmental regulation of oligosialylation in zebrafish
2008
Guillain-Barré syndrome after exposure to influenza virus
2010
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality
2005
Campylobacter jejuniInfection and Guillain–Barré Syndrome
1995
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients
2004
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides
1995
Guillain‐Barré Syndrome Animal Model: The First Proof of Molecular Mimicry in Human Autoimmune Disorder
2010
Animal models of chronic obstructive pulmonary disease
2008
Carbohydrate mimicry: a new paradigm of autoimmune diseases
2005
Polyamine-rich food decreases age-associated pathology and mortality in aged mice
2009
Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome
2003
Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study
2011
Guillain-Barré syndrome
2016 Standout
Head and neck cancer
2008 Standout
A review of stimuli-responsive nanocarriers for drug and gene delivery
2008 Standout
Blood γδ T cells, Campylobacter jejuni, and GM1 titers in Guillain–Barré syndrome
2004
Guillain–Barré Syndrome
2012 Standout
Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain‐Barré syndrome and Fisher's syndrome
1997
The immunobiology of Guillain‐Barré syndromes
2005
Does renal ageing affect survival?
2007
Immunopathogenesis and treatment of the guillain–barré syndrome—part II
1995
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
2004
Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice
2014
Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids
2000
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
2015 StandoutNobel
Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome
1995
Chemotaxonomy and geographical distribution of tropane alkaloids
2000
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
1999
Identification of the Sulfated Monosaccharides of GlyCAM-1, an Endothelial-Derived Ligand for L-Selectin
1994 StandoutNobel
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
1994 Standout
Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome
1995
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes
2016
Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain—Barré syndrome subsequent to Campylobacter jejuni enteritis
1996
Microbiologic Approaches for StudyingCampylobacterSpecies in Patients with Guillain‐Barré Syndrome
1997
Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies
2013
Ganglioside GM1 Mimicry inCampylobacterStrains from Sporadic Infections in the United States
1999
Comprehensive Analysis of Bacterial Risk Factors for the Development of Guillain‐Barré Syndrome afterCampylobacter jejuniEnteritis
2006
Pathology of the motor‐sensory axonal Guillain‐Barré syndrome
1996
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Activated non-neural specific T cells open the blood–brain barrier to circulating antibodies
1999
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal
2001
Axonal Guillain-Barré syndrome: concepts and controversies
2013
Activated T cells of nonneural specificity open the blood‐nerve barrier to circulating antibody
1995
Guillain-Barré syndrome
1998
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
1999
Myocarditis
2000 Standout
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
2009
Gut microbiota, metabolites and host immunity
2016 Standout
Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a
2000
Peripheral neuropathies and anti-glycolipid antibodies
2002
Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
1999
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry
1995
Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection
1996
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection
1995
Ability to Remove Immunoglobulins and Antiganglioside Antibodies by Double Filtration Plasmapheresis in Guillain‐Barré Syndrome: Is It Equivalent to Plasma Exchange?
1997
The selectins and their ligands
1994 StandoutNobel
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
The Hallmarks of Aging
2013 Standout
Removing the Vertebrate-Specific TBP N Terminus Disrupts Placental β2m-Dependent Interactions with the Maternal Immune System
2002 StandoutNobel
Cross-Reactive Antibodies against Gangliosides and Campylobacter jejuni Lipopolysaccharides in Patients with Guillaln-Barre or Miller Fisher Syndrome
1997
Uptake and metabolism of exogenous glycosphingolipids by cultured cells
2001
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Haemophilus influenzae infection and Guillain-Barre syndrome
2000
Guillain-Barr?? Syndrome
2004
Pathogenesis of Guillain–Barré syndrome
1999
The inflammatory reflex
2002 StandoutNature
Cancer vaccines and carbohydrate epitopes
2011
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
The risk of Guillain–Barré syndrome following infection with Campylobacter jejuni
1999
Structural studies on human 2-oxoglutarate dependent oxygenases
2010
Palladium and Platinum Nanoparticles Attenuate Aging-Like Skin Atrophy via Antioxidant Activity in Mice
2014
Guillain-Barré syndrome
2005 Standout
Autoimmune responses in peripheral nerve
1996
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside
2001
Acute motor conduction block neuropathy Another Guillain–Barre syndrome variant
2003
Isolation and characterization of a heptaglycosylceramide from bovine erythrocyte membranes.
1979
Campylobacter jejunifrom Patients with Guillain-Barre Syndrome Preferentially Expresses a GD1a-Like Epitope
2002
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barre syndrome
2000
Retroelements and the human genome: New perspectives on an old relation
2004
Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.
1996
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy
2012
Guillain-Barr� syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies
1995
AHaemophilus influenzaeStrain Associated with Fisher Syndrome Expresses a Novel Disialylated Ganglioside Mimic
2007
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome
2004
Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3
1996
Clinical features and prognosis of Miller Fisher syndrome
2001
Molecular mimicry: Can epitope mimicry induce autoimmune disease?
1997
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
2002
Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry
2001
Loco Intoxication: Indolizidine Alkaloids of Spotted Locoweed ( Astragalus lentiginosus )
1982 Science
Immunolocalization of GQ1b and Related Gangliosides in Human Extraocular Neuromuscular Junctions and Muscle Spindles
2009
Spermidine in health and disease
2018 StandoutScience
Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome (GBS)
1997
Carbohydrate recognition in the peripheral nervous system: a calcium-dependent membrane binding site for HNK-1 reactive glycolipids potentially involved in Schwann cell adhesion.
1993
Antecedent infections in Fisher syndrome
2005
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
1988 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Viruses as potential pathogenic agents in systemic lupus erythematosus
2014
The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin.
1993
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Effect of isomers of swainsonine on glycosidase activity and glycoprotein processing
1987 StandoutNobel
Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy
2014 StandoutNobel
Association of FcγRII with Low-Density Detergent-Resistant Membranes Is Important for Cross-Linking-Dependent Initiation of the Tyrosine Phosphorylation Pathway and Superoxide Generation
2001
Acute motor axonal neuropathy after Mycoplasma infection
2004
Extrathymic Development of Vα11 T Cells in Placenta During Pregnancy and Their Possible Physiological Role
2001
The Guillain–Barré syndrome: a true case of molecular mimicry
2003
Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM 1 Ganglioside
1998
Reduction of Amine N-Oxides by Diboron Reagents
2011
Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan
2000
Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth
2014 StandoutNobel
Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome
1999
Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies
1998
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
2003 Standout
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Miller Fisher syndrome and Haemophilus influenzae infection
2001
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
HLA class II alleles are not a general susceptibility factor in Guillain–Barre syndrome
2005
Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?
1994
OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation
2014 StandoutNobel
Differential Distribution of HLA-DQβ/DRβ Epitopes in the Two Forms of Guillain-Barre Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQβ Epitopes Associated with Susceptibility to and Protection from AIDP
2003
Works of Setsuko Handa being referenced
Detection of Antibodies to a Recombinant gag Protein Derived from Human Endogenous Retrovirus Clone 4-1 in Autoimmune Diseases
1997
Senescence Marker Protein-30 Knockout Mouse Liver Is Highly Susceptible to Tumor Necrosis Factor-α- and Fas-Mediated Apoptosis
2002
Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy
1997
Microscale analysis of glycosphingolipids by TLC blotting/secondary ion mass spectrometry: a novel blood group A-active glycosphingolipid and changes in glycosphingolipid expression in rat mammary tumour cells with different metastatic potentials
1996
The strain-dependent constitutive expression of murine serum amyloid-P component is regulated at the transcriptional level
1992
Antibodies to GT1a ganglioside in patients with Guillain–Barré syndrome
1998
Senescence marker protein‐30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis
2014
Analysis of glycosphingolipids of human head and neck carcinomas with comparison to normal tissue
1998
Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome
1994
Isolation and Characterization of a Novel Forssman Active Acidic Glycosphingolipid with Branched Isoglobo-, Ganglio-, and Neolacto-Series Hybrid Sugar Chains
1999
Senescence marker protein‐30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver
2004
N-oxides of hyoscyamine and hyoscine in the solanaceae
1975
Vitamin C Is Not Essential for Carnitine Biosynthesis in Vivo: Verification in Vitamin C-Depleted Senescence Marker Protein-30/Gluconolactonase Knockout Mice
2008
Mono-sulfated Globopentaosylceramide from Human Kidney
1989
A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure.
1993
Uptake and metabolism of radiolabelled GM1‐ganglioside in skin fibroblasts from controls and patients with GM1‐gangliosidosis
1990
Human meconium gangliosides. Characterization of a novel I-type ganglioside with the NeuAc alpha 2-6Gal structure.
1992
Nicotine N-oxides
1975
Chemical structure of the main glycolipid of hog erythrocytes.
1968
Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope
1994
A Sulfated Glucosylceramide from Rat Kidney
1989
The chemistry of lipids of posthemolytic residue or stroma of erythrocytes. XIV. Chemical structure of glycolipid of cat erythrocyte stroma.
1965
Accelerated tubular cell senescence in SMP30 knockout mice.
2006
Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice
2008